APO Research
Talk to an analyst

APO RESEARCH · REPORT

Enzyme-Linked Immunosorbent Assay (ELISA)

ELISAs (Enzyme-linked immunosorbent assays) are routinely used for the qualitative and quantitative assessment of cytokines, chemokines, growth factors, phosphorylated targets, immunoglobulins and other immunological markers. Detection and quantitation of protein analytes from various biological samples—serum, plasma, cell culture supernatants and cell lysates—indicate a multitude of biological and pathological events. ELISAs have proven to be valuable tools in drug development as they are commonly used for biomarker profiling of disease vs. normal states, as well as toxicity profiling.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

ELISAs (Enzyme-linked immunosorbent assays) are routinely used for the qualitative and quantitative assessment of cytokines, chemokines, growth factors, phosphorylated targets, immunoglobulins and other immunological markers. Detection and quantitation of protein analytes from various biological samples—serum, plasma, cell culture supernatants and cell lysates—indicate a multitude of biological and pathological events. ELISAs have proven to be valuable tools in drug development as they are commonly used for biomarker profiling of disease vs. normal states, as well as toxicity profiling.

Selected research

Market Outlook & Growth Opportunities

Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Outlook and Growth Opportunities 2026

21 December 2025196 pages

Choose your research edition.

Industry ResearchEnzyme-Linked Immunosorbent Assay (ELISA) Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Enzyme-Linked Immunosorbent Assay (ELISA) Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Enzyme-Linked Immunosorbent Assay (ELISA) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Enzyme-Linked Immunosorbent Assay (ELISA) Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Enzyme-Linked Immunosorbent Assay (ELISA) Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

ELISAs (Enzyme-linked immunosorbent assays) are routinely used for the qualitative and quantitative assessment of cytokines, chemokines, growth factors, phosphorylated targets, immunoglobulins and other immunological markers. Detection and quantitation of protein analytes from various biological samples—serum, plasma, cell culture supernatants and cell lysates—indicate a multitude of biological and pathological events. ELISAs have proven to be valuable tools in drug development as they are commonly used for biomarker profiling of disease vs. normal states, as well as toxicity profiling.

Global Enzyme-Linked Immunosorbent Assay (ELISA) key players include R&D Systems, Thermo Fisher Scientific, Ortho Clinical Diagnostics, BD Biosciences, etc. Global top four manufacturers hold a share over 45%.

China is the largest market, with a share over 35%, followed by Europe, and USA, both have a share over 30 percent.

Read the full market overview

In terms of product, Indirect ELISA is the largest segment, with a share over 45%. And in terms of application, the largest application is Immunology, followed by Infectious Diseases, Protein Quantitation, Cancer, etc.

This report provides an overview of the global Enzyme-Linked Immunosorbent Assay (ELISA) market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Enzyme-Linked Immunosorbent Assay (ELISA) and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Enzyme-Linked Immunosorbent Assay (ELISA) revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Enzyme-Linked Immunosorbent Assay (ELISA) market.

Enzyme-Linked Immunosorbent Assay (ELISA) Segment by Company

R&D Systems

Thermo Fisher Scientific

Ortho Clinical Diagnostics

BD Biosciences

ZEUS Scientific

Bio-Rad Laboratories

ALPCO

Enzo Life Sciences

BioMérieux

EMD Millipore

BioLegend

LOEWE Biochemica

Mercodia

Cusabio

Shanghai Kehua Bio-engineering

Enzyme-Linked Immunosorbent Assay (ELISA) Segment by Type

Sandwich ELISA

Indirect ELISA

Competitive ELISA

Others

Enzyme-Linked Immunosorbent Assay (ELISA) Segment by Application

Immunology

Inflammation

Infectious Diseases

Cancer

Protein Quantitation

Others

Enzyme-Linked Immunosorbent Assay (ELISA) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Enzyme-Linked Immunosorbent Assay (ELISA) status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Enzyme-Linked Immunosorbent Assay (ELISA) key companies, revenue, market share, and recent developments.

3. To split the Enzyme-Linked Immunosorbent Assay (ELISA) breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Enzyme-Linked Immunosorbent Assay (ELISA) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Enzyme-Linked Immunosorbent Assay (ELISA) significant trends, drivers, influence factors in global and regions.

6. To analyze Enzyme-Linked Immunosorbent Assay (ELISA) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Enzyme-Linked Immunosorbent Assay (ELISA) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Enzyme-Linked Immunosorbent Assay (ELISA) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Enzyme-Linked Immunosorbent Assay (ELISA).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Enzyme-Linked Immunosorbent Assay (ELISA) industry.

Chapter 3: Detailed analysis of Enzyme-Linked Immunosorbent Assay (ELISA) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Enzyme-Linked Immunosorbent Assay (ELISA) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Enzyme-Linked Immunosorbent Assay (ELISA) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Enzyme-Linked Immunosorbent Assay (ELISA) Industry Trends Table 2. Enzyme-Linked Immunosorbent Assay (ELISA) Industry Drivers Table 3. Enzyme-Linked Immunosorbent Assay (ELISA) Industry Opportunities and Challenges Table 4. Enzyme-Linked Immunosorbent Assay (ELISA) Industry Restraints Table 5. Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Share by Company (2021-2026) Table 7. Global Enzyme-Linked Immunosorbent Assay (ELISA) Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Enzyme-Linked Immunosorbent Assay (ELISA) Key Company Manufacturing Base & Headquarters Table 9. Global Enzyme-Linked Immunosorbent Assay (ELISA) Company, Product Type & Application Table 10. Global Enzyme-Linked Immunosorbent Assay (ELISA) Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Enzyme-Linked Immunosorbent Assay (ELISA) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Sandwich ELISA Table 15. Significant Companies of Indirect ELISA Table 16. Significant Companies of Competitive ELISA Table 17. Significant Companies of Others Table 18. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type (2021-2026) Table 22. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Immunology Table 24. Significant Companies of Inflammation Table 25. Significant Companies of Infectious Diseases Table 26. Significant Companies of Cancer Table 27. Significant Companies of Protein Quantitation Table 28. Significant Companies of Others Table 29. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Application (2021-2026) & (US$ Million) Table 31. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Application (2027-2032) & (US$ Million) Table 32. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application (2021-2026) Table 33. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application (2027-2032) Table 34. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Region (2021-2026) & (US$ Million) Table 36. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Region (2021-2026) Table 37. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Region (2027-2032) & (US$ Million) Table 38. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Region (2027-2032) Table 39. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Country (2021-2026) & (US$ Million) Table 41. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Market Share by Country (2021-2026) Table 42. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Country (2027-2032) & (US$ Million) Table 43. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Market Share by Country (2027-2032) Table 44. R&D Systems Company Information Table 45. R&D Systems Business Overview Table 46. R&D Systems Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. R&D Systems Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio Table 48. R&D Systems Recent Development Table 49. Thermo Fisher Scientific Company Information Table 50. Thermo Fisher Scientific Business Overview Table 51. Thermo Fisher Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Thermo Fisher Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio Table 53. Thermo Fisher Scientific Recent Development Table 54. Ortho Clinical Diagnostics Company Information Table 55. Ortho Clinical Diagnostics Business Overview Table 56. Ortho Clinical Diagnostics Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Ortho Clinical Diagnostics Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio Table 58. Ortho Clinical Diagnostics Recent Development Table 59. BD Biosciences Company Information Table 60. BD Biosciences Business Overview Table 61. BD Biosciences Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. BD Biosciences Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio Table 63. BD Biosciences Recent Development Table 64. ZEUS Scientific Company Information Table 65. ZEUS Scientific Business Overview Table 66. ZEUS Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. ZEUS Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio Table 68. ZEUS Scientific Recent Development Table 69. Bio-Rad Laboratories Company Information Table 70. Bio-Rad Laboratories Business Overview Table 71. Bio-Rad Laboratories Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Bio-Rad Laboratories Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio Table 73. Bio-Rad Laboratories Recent Development Table 74. ALPCO Company Information Table 75. ALPCO Business Overview Table 76. ALPCO Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. ALPCO Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio Table 78. ALPCO Recent Development Table 79. Enzo Life Sciences Company Information Table 80. Enzo Life Sciences Business Overview Table 81. Enzo Life Sciences Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Enzo Life Sciences Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio Table 83. Enzo Life Sciences Recent Development Table 84. BioMérieux Company Information Table 85. BioMérieux Business Overview Table 86. BioMérieux Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. BioMérieux Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio Table 88. BioMérieux Recent Development Table 89. EMD Millipore Company Information Table 90. EMD Millipore Business Overview Table 91. EMD Millipore Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. EMD Millipore Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio Table 93. EMD Millipore Recent Development Table 94. BioLegend Company Information Table 95. BioLegend Business Overview Table 96. BioLegend Enzyme-Linked Immunosorbent Assay (ELISA) Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 97. BioLegend Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio Table 98. BioLegend Recent Development Table 99. LOEWE Biochemica Company Information Table 100. LOEWE Biochemica Business Overview Table 101. LOEWE Biochemica Enzyme-Linked Immunosorbent Assay (ELISA) Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 102. LOEWE Biochemica Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio Table 103. LOEWE Biochemica Recent Development Table 104. Mercodia Company Information Table 105. Mercodia Business Overview Table 106. Mercodia Enzyme-Linked Immunosorbent Assay (ELISA) Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 107. Mercodia Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio Table 108. Mercodia Recent Development Table 109. Cusabio Company Information Table 110. Cusabio Business Overview Table 111. Cusabio Enzyme-Linked Immunosorbent Assay (ELISA) Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 112. Cusabio Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio Table 113. Cusabio Recent Development Table 114. Shanghai Kehua Bio-engineering Company Information Table 115. Shanghai Kehua Bio-engineering Business Overview Table 116. Shanghai Kehua Bio-engineering Enzyme-Linked Immunosorbent Assay (ELISA) Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 117. Shanghai Kehua Bio-engineering Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio Table 118. Shanghai Kehua Bio-engineering Recent Development Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. Enzyme-Linked Immunosorbent Assay (ELISA) Product Image Figure 2. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size (2021-2032) & (US$ Million) Figure 4. Global Enzyme-Linked Immunosorbent Assay (ELISA) Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Sandwich ELISA Image Figure 8. Indirect ELISA Image Figure 9. Competitive ELISA Image Figure 10. Others Image Figure 11. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type (2021-2032) Figure 14. Immunology Image Figure 15. Inflammation Image Figure 16. Infectious Diseases Image Figure 17. Cancer Image Figure 18. Protein Quantitation Image Figure 19. Others Image Figure 20. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share 2021 VS 2025 VS 2032 Figure 22. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application (2021-2032) Figure 23. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 24. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 25. North America Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value (2021-2032) & (US$ Million) Figure 26. North America Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value (2021-2032) & (US$ Million) Figure 28. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value (2021-2032) & (US$ Million) Figure 30. Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Country (%), 2025 VS 2032 Figure 31. South America Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value (2021-2032) & (US$ Million) Figure 32. South America Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value (2021-2032) & (US$ Million) Figure 34. Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Country (%), 2025 VS 2032 Figure 35. USA Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. USA Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. USA Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Canada Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Canada Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Canada Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Mexico Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Mexico Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Mexico Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Germany Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Germany Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Germany Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. France Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. France Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. France Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. U.K. Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. U.K. Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. U.K. Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Italy Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Italy Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Italy Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Spain Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Spain Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Spain Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Russia Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Russia Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Russia Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Netherlands Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Netherlands Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Netherlands Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Nordic Countries Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Nordic Countries Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Nordic Countries Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. China Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. China Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. China Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Japan Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Japan Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Japan Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. South Korea Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. South Korea Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. South Korea Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. India Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. India Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. India Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Australia Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Australia Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Australia Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Southeast Asia Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Southeast Asia Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Southeast Asia Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Brazil Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Brazil Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Brazil Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Argentina Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Argentina Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Argentina Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Chile Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Chile Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Chile Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Colombia Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Colombia Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Colombia Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Peru Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Peru Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Peru Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Saudi Arabia Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Saudi Arabia Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Israel Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Israel Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Israel Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. UAE Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. UAE Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. UAE Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Turkey Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Turkey Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Turkey Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Iran Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Iran Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Iran Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Egypt Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Egypt Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Egypt Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Years Considered Figure 120. Research Process Figure 121. Key Executives Interviewed

Scope & coverage.

Types
  • Sandwich ELISA
  • Indirect ELISA
  • Competitive ELISA
  • Others
Applications
  • Immunology
  • Inflammation
  • Infectious Diseases
  • Cancer
  • Protein Quantitation
  • Others
Companies covered
  • R&D Systems
  • Thermo Fisher Scientific
  • Ortho Clinical Diagnostics
  • BD Biosciences
  • ZEUS Scientific
  • Bio-Rad Laboratories
  • ALPCO
  • Enzo Life Sciences
  • BioMérieux
  • EMD Millipore
  • BioLegend
  • LOEWE Biochemica
  • Mercodia
  • Cusabio
  • Shanghai Kehua Bio-engineering

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Enzyme-Linked Immunosorbent Assay (ELISA) Market Dynamics
  1. 2.1 Enzyme-Linked Immunosorbent Assay (ELISA) Industry Trends
  2. 2.2 Enzyme-Linked Immunosorbent Assay (ELISA) Industry Drivers
  3. 2.3 Enzyme-Linked Immunosorbent Assay (ELISA) Industry Opportunities and Challenges
  4. 2.4 Enzyme-Linked Immunosorbent Assay (ELISA) Industry Restraints
3 Enzyme-Linked Immunosorbent Assay (ELISA) Market by Company
  1. 3.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Company Revenue Ranking in 2025
  2. 3.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Company (2021-2026)
  3. 3.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Company Ranking (2024-2026)
  4. 3.4 Global Enzyme-Linked Immunosorbent Assay (ELISA) Company Manufacturing Base and Headquarters
  5. 3.5 Global Enzyme-Linked Immunosorbent Assay (ELISA) Company Product Type and Application
  6. 3.6 Global Enzyme-Linked Immunosorbent Assay (ELISA) Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Enzyme-Linked Immunosorbent Assay (ELISA) Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Enzyme-Linked Immunosorbent Assay (ELISA) Market by Type
  1. 4.1 Enzyme-Linked Immunosorbent Assay (ELISA) Type Introduction
  2. 4.1.1 Sandwich ELISA
  3. 4.1.2 Indirect ELISA
  4. 4.1.3 Competitive ELISA
  5. 4.1.4 Others
  6. 4.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Type
  7. 4.2.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Type (2021-2032)
  9. 4.2.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type (2021-2032)
5 Enzyme-Linked Immunosorbent Assay (ELISA) Market by Application
  1. 5.1 Enzyme-Linked Immunosorbent Assay (ELISA) Application Introduction
  2. 5.1.1 Immunology
  3. 5.1.2 Inflammation
  4. 5.1.3 Infectious Diseases
  5. 5.1.4 Cancer
  6. 5.1.5 Protein Quantitation
  7. 5.1.6 Others
  8. 5.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Application
  9. 5.2.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Application (2021-2032)
  11. 5.2.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application (2021-2032)
6 Enzyme-Linked Immunosorbent Assay (ELISA) Regional Value Analysis
  1. 6.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Region (2021-2032)
  3. 6.2.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Region: 2021-2026
  4. 6.2.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value (2021-2032)
  7. 6.3.2 North America Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value (2021-2032)
  10. 6.4.2 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value (2021-2032)
  16. 6.6.2 South America Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Country, 2025 VS 2032
7 Enzyme-Linked Immunosorbent Assay (ELISA) Country-level Value Analysis
  1. 7.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Country (2021-2032)
  3. 7.2.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Country (2021-2026)
  4. 7.2.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 R&D Systems
  2. 8.1.1 R&D Systems Company Information
  3. 8.1.2 R&D Systems Business Overview
  4. 8.1.3 R&D Systems Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Gross Margin (2021-2026)
  5. 8.1.4 R&D Systems Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
  6. 8.1.5 R&D Systems Recent Developments
  7. 8.2 Thermo Fisher Scientific
  8. 8.2.1 Thermo Fisher Scientific Company Information
  9. 8.2.2 Thermo Fisher Scientific Business Overview
  10. 8.2.3 Thermo Fisher Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Thermo Fisher Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
  12. 8.2.5 Thermo Fisher Scientific Recent Developments
  13. 8.3 Ortho Clinical Diagnostics
  14. 8.3.1 Ortho Clinical Diagnostics Company Information
  15. 8.3.2 Ortho Clinical Diagnostics Business Overview
  16. 8.3.3 Ortho Clinical Diagnostics Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Ortho Clinical Diagnostics Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
  18. 8.3.5 Ortho Clinical Diagnostics Recent Developments
  19. 8.4 BD Biosciences
  20. 8.4.1 BD Biosciences Company Information
  21. 8.4.2 BD Biosciences Business Overview
  22. 8.4.3 BD Biosciences Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Gross Margin (2021-2026)
  23. 8.4.4 BD Biosciences Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
  24. 8.4.5 BD Biosciences Recent Developments
  25. 8.5 ZEUS Scientific
  26. 8.5.1 ZEUS Scientific Company Information
  27. 8.5.2 ZEUS Scientific Business Overview
  28. 8.5.3 ZEUS Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Gross Margin (2021-2026)
  29. 8.5.4 ZEUS Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
  30. 8.5.5 ZEUS Scientific Recent Developments
  31. 8.6 Bio-Rad Laboratories
  32. 8.6.1 Bio-Rad Laboratories Company Information
  33. 8.6.2 Bio-Rad Laboratories Business Overview
  34. 8.6.3 Bio-Rad Laboratories Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Bio-Rad Laboratories Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
  36. 8.6.5 Bio-Rad Laboratories Recent Developments
  37. 8.7 ALPCO
  38. 8.7.1 ALPCO Company Information
  39. 8.7.2 ALPCO Business Overview
  40. 8.7.3 ALPCO Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Gross Margin (2021-2026)
  41. 8.7.4 ALPCO Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
  42. 8.7.5 ALPCO Recent Developments
  43. 8.8 Enzo Life Sciences
  44. 8.8.1 Enzo Life Sciences Company Information
  45. 8.8.2 Enzo Life Sciences Business Overview
  46. 8.8.3 Enzo Life Sciences Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Enzo Life Sciences Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
  48. 8.8.5 Enzo Life Sciences Recent Developments
  49. 8.9 BioMérieux
  50. 8.9.1 BioMérieux Company Information
  51. 8.9.2 BioMérieux Business Overview
  52. 8.9.3 BioMérieux Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Gross Margin (2021-2026)
  53. 8.9.4 BioMérieux Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
  54. 8.9.5 BioMérieux Recent Developments
  55. 8.10 EMD Millipore
  56. 8.10.1 EMD Millipore Company Information
  57. 8.10.2 EMD Millipore Business Overview
  58. 8.10.3 EMD Millipore Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Gross Margin (2021-2026)
  59. 8.10.4 EMD Millipore Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
  60. 8.10.5 EMD Millipore Recent Developments
  61. 8.11 BioLegend
  62. 8.11.1 BioLegend Company Information
  63. 8.11.2 BioLegend Business Overview
  64. 8.11.3 BioLegend Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Gross Margin (2021-2026)
  65. 8.11.4 BioLegend Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
  66. 8.11.5 BioLegend Recent Developments
  67. 8.12 LOEWE Biochemica
  68. 8.12.1 LOEWE Biochemica Company Information
  69. 8.12.2 LOEWE Biochemica Business Overview
  70. 8.12.3 LOEWE Biochemica Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Gross Margin (2021-2026)
  71. 8.12.4 LOEWE Biochemica Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
  72. 8.12.5 LOEWE Biochemica Recent Developments
  73. 8.13 Mercodia
  74. 8.13.1 Mercodia Company Information
  75. 8.13.2 Mercodia Business Overview
  76. 8.13.3 Mercodia Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Mercodia Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
  78. 8.13.5 Mercodia Recent Developments
  79. 8.14 Cusabio
  80. 8.14.1 Cusabio Company Information
  81. 8.14.2 Cusabio Business Overview
  82. 8.14.3 Cusabio Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Cusabio Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
  84. 8.14.5 Cusabio Recent Developments
  85. 8.15 Shanghai Kehua Bio-engineering
  86. 8.15.1 Shanghai Kehua Bio-engineering Company Information
  87. 8.15.2 Shanghai Kehua Bio-engineering Business Overview
  88. 8.15.3 Shanghai Kehua Bio-engineering Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Shanghai Kehua Bio-engineering Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
  90. 8.15.5 Shanghai Kehua Bio-engineering Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst